MLchartDataset catalogue

Oncology and biomedicine terminology · MLC-0111

Oncology and biomedicine acronyms: L (57)

Table 1. Acronyms and abbreviations
AcronymExpansion
L. rhamnosus/L. jensenii/L. crispatus/L. gasseri oral supplementLactobacillus rhamnosus/L. jensenii/L. crispatus/L. gasseri oral supplement
L19-IL2bifikafusp alfa
LAKlymphokine-activated killer cells
L-AMBliposomal amphotericin B
LAPdalpha-lipoic acid-palladium/vitamin/mineral supplement
LAPS-GCSFeflapegrastim
L-ASPasparaginase
L-ATRAliposomal tretinoin
LCHLangerhans cell histiocytosis
LCISlobular carcinoma in situ
LCLTL-carnitine L-tartrate
LC-MSliquid chromatography-mass spectrometry
LDlinkage disequilibrium
LDCTlow-dose computed tomography; low-dose CT scan
LDE225erismodegib; Odomzo; sonidegib phosphate
LDHlactate dehydrogenase; lactic acid dehydrogenase
LE-DTliposomal docetaxel
LEEPloop electrosurgical excision procedure; loop excision
LEP-ETUliposomal paclitaxel; LipoTaxen; paclitaxel liposome
LEUPleuprolide acetate
LEVlevamisole hydrochloride
L-FMAUclevudine
LFSLi-Fraumeni syndrome
LGD1069bexarotene; Targretin
L-Grb-2liposome-incorporated Grb2 antisense oligodeoxynucleotide
LHinterstitial cell-stimulating hormone; luteinizing hormone; lutropin
LH-RHgonadotropin-releasing hormone; luteinizing hormone-releasing hormone
LHRHgonadotropin-releasing hormone; luteinizing hormone-releasing hormone
LINlobular intraepithelial neoplasia; lobular neoplasia
LITTlaser interstitial thermal therapy
LLMEL-leucyl-L-leucine methyl ester
LMB-1LMB-1 immunotoxin
LMB-2LMB-2 immunotoxin
LMHhoney-based nutritional supplement
LMP2A CTLLMP2a-specific cytotoxic T-lymphocytes
L-MTP-PEmifamurtide; muramyl tripeptide phosphatidylethanolamine
LMTXlometrexol
L-NDDPliposomal NDDP
LNG-IUSlevonorgestrel-releasing intrauterine system
L-NNANG-nitro-L-arginine
LOELindera obtusiloba extract
LOHloss of heterozygosity
L-OHPoxaliplatin
LOXO-101larotrectinib sulfate; Trk inhibitor LOXO-101; Vitrakvi
LPlumbar puncture; spinal tap
Lp 299vLactobacillus plantarum strain 299v
L-PAMmelphalan
LPHLnodular lymphocyte-predominant Hodgkin lymphoma
LPSlipopolysaccharide
LPV7long peptide vaccine 7
LSILlow-grade squamous intraepithelial lesion
LVAlymphaticovenous anastomosis; lymphovenous bypass
LVBlymphaticovenous anastomosis; lymphovenous bypass
LY231514Alimta; pemetrexed disodium; Pemfexy
LY317615enzastaurin hydrochloride
LY335979zosuquidar trihydrochloride
LYCOlycopene

Oncology and biomedicine terminology (MLC-0111). Request the full dataset.